Iron and transfusion medicine.

[1]  Yvonne Vergouwe,et al.  External validation and updating of a Dutch prediction model for low hemoglobin deferral in Irish whole blood donors , 2014, Transfusion.

[2]  S. McNaughton,et al.  Iron status and dietary iron intake of female blood donors , 2014, Transfusion.

[3]  T. Simon,et al.  Laboratory variables for assessing iron deficiency in REDS‐II Iron Status Evaluation (RISE) blood donors , 2013, Transfusion.

[4]  B. Favrat,et al.  Validation of hepcidin quantification in plasma using LC-HRMS and discovery of a new hepcidin isoform. , 2013, Bioanalysis.

[5]  Giuseppe Remuzzi,et al.  Monogenic diseases that can be cured by liver transplantation. , 2013, Journal of hepatology.

[6]  Y. Vergouwe,et al.  Zinc protoporphyrin levels have added value in the prediction of low hemoglobin deferral in whole blood donors , 2013, Transfusion.

[7]  S. Glynn,et al.  Restless legs syndrome, pica, and iron status in blood donors , 2013, Transfusion.

[8]  D. Swinkels,et al.  High prevalence of subclinical iron deficiency in whole blood donors not deferred for low hemoglobin , 2013, Transfusion.

[9]  J. A. Hopkins,et al.  Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome , 2013, Transfusion.

[10]  S. Glynn,et al.  Hepcidin level predicts hemoglobin concentration in individuals undergoing repeated phlebotomy , 2013, Haematologica.

[11]  Alan D. Lopez,et al.  Measuring the global burden of disease. , 2013, The New England journal of medicine.

[12]  J. Walley,et al.  Ferritin levels and risk of type 2 diabetes mellitus: an updated systematic review and meta‐analysis of prospective evidence , 2013, Diabetes/metabolism research and reviews.

[13]  Jun Zhu,et al.  Development of GMDR-GPU for Gene-Gene Interaction Analysis and Its Application to WTCCC GWAS Data for Type 2 Diabetes , 2013, PloS one.

[14]  D. Pennell,et al.  On myocardial siderosis and left ventricular dysfunction in hemochromatosis , 2013, Journal of Cardiovascular Magnetic Resonance.

[15]  D. McClain,et al.  Iron and diabetes risk. , 2013, Cell metabolism.

[16]  A. Piperno.  Molecular diagnosis of hemochromatosis. , 2013, Expert opinion on medical diagnostics.

[17]  D. Girelli,et al.  CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients , 2012, Haematologica.

[18]  Y. Vergouwe,et al.  Development and validation of a prediction model for low hemoglobin deferral in a large cohort of whole blood donors , 2012, Transfusion.

[19]  B. Favrat,et al.  [Iron deficiency without anemia: where are we in 2012?]. , 2012, Revue medicale suisse.

[20]  Wei Bao,et al.  Dietary iron intake, body iron stores, and the risk of type 2 diabetes: a systematic review and meta-analysis , 2012, BMC Medicine.

[21]  A. Buser,et al.  Switching iron‐deficient whole blood donors to plateletpheresis , 2012, Transfusion.

[22]  B. Favrat,et al.  W472 A SINGLE 1000 MG IRON DOSE OF FERRIC CARBOXYMALTOSE IMPROVES FATIGUE IN IRON DEFICIENT, NON‐ANAEMIC PREMENOPAUSAL WOMEN – RESULTS OF THE RANDOMISED, PLACEBO‐CONTROLLED PREFER STUDY , 2012 .

[23]  B. Favrat,et al.  Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial , 2012, Canadian Medical Association Journal.

[24]  H. Tian,et al.  Body Iron Stores and Heme-Iron Intake in Relation to Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis , 2012, PloS one.

[25]  A. Tartakoff,et al.  Mechanisms of mammalian iron homeostasis. , 2012, Biochemistry.

[26]  M. Raikhel.  Accuracy of Noninvasive and Invasive Point-of-Care Total Blood Hemoglobin Measurement in an Outpatient Setting , 2012, Postgraduate medicine.

[27]  S. Annaheim,et al.  Haematocrit is invalid for estimating red cell volume: a prospective study in male volunteers. , 2012, Blood transfusion = Trasfusione del sangue.

[28]  S. Kleinman,et al.  The difference between fingerstick and venous hemoglobin and hematocrit varies by sex and iron stores , 2012, Transfusion.

[29]  A. Buser,et al.  Prognostic value of red blood cell parameters and ferritin in predicting deferral due to low hemoglobin in whole blood donors , 2012, Annals of Hematology.

[30]  S. Glynn,et al.  Iron deficiency in blood donors: the REDS‐II Donor Iron Status Evaluation (RISE) study , 2012, Transfusion.

[31]  K. Kowdley,et al.  Review article: the iron overload syndromes , 2012, Alimentary pharmacology & therapeutics.

[32]  Xu Lin,et al.  Association of TMPRSS6 polymorphisms with ferritin, hemoglobin, and type 2 diabetes risk in a Chinese Han population. , 2012, The American journal of clinical nutrition.

[33]  J. Cornuz,et al.  Clinical evaluation of iron treatment efficiency among non-anemic but iron-deficient female blood donors: a randomized controlled trial , 2012, BMC Medicine.

[34]  E. Gayat,et al.  Non-Invasive Measurement of Hemoglobin: Assessment of Two Different Point-of-Care Technologies , 2012, PloS one.

[35]  E. Wood,et al.  Hemoglobin and iron indices in nonanemic premenopausal blood donors predict future deferral from whole blood donation , 2011, Transfusion.

[36]  J. Krieger,et al.  Genotyping of the hemochromatosis HFE p.H63D and p.C282Y mutations by high-resolution melting with the Rotor-Gene 6000® instrument , 2011, Clinical chemistry and laboratory medicine.

[37]  J. Adamson,et al.  Ironing out fatigue , 2011, Blood.

[38]  E. Wood,et al.  Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors , 2011, Haematologica.

[39]  Tomas Ganz,et al.  Hepcidin and iron regulation, 10 years later. , 2011, Blood.

[40]  J. Krieger,et al.  Hereditary hemochromatosis: mutations in genes involved in iron homeostasis in Brazilian patients. , 2011, Blood cells, molecules & diseases.

[41]  J. Kaplan,et al.  The molecular basis of iron overload disorders and iron-linked anemias , 2011, International journal of hematology.

[42]  G. Pacini,et al.  Glucose metabolism after normalization of markers of iron overload by venesection in subjects with hereditary hemochromatosis. , 2010, Metabolism: clinical and experimental.

[43]  A. Buser,et al.  The value of routine ferritin measurement in blood donors , 2010, Transfusion.

[44]  J. Krieger,et al.  HJV Hemochromatosis, Iron Overload, and Hypogonadism in a Brazilian Man: Treatment with Phlebotomy and Deferasirox , 2010, Acta Haematologica.

[45]  R. Plomin,et al.  DNA methylation profiling using bisulfite-based epityping of pooled genomic DNA. , 2010, Methods.

[46]  J. Robens.  Hepcidin: the link to understanding iron regulation. , 2010, MLO: medical laboratory observer.

[47]  Y. Naito,et al.  Iron restriction improves type 2 diabetes mellitus in Otsuka Long-Evans Tokushima fatty rats. , 2010, American journal of physiology. Endocrinology and metabolism.

[48]  H. Rienhoff,et al.  Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. , 2010, American journal of physiology. Endocrinology and metabolism.

[49]  S. Paik,et al.  A rapid, sensitive, reproducible and cost-effective method for mutation profiling of colon cancer and metastatic lymph nodes , 2010, BMC Cancer.

[50]  G. Pacini,et al.  Effect of iron overload on glucose metabolism in patients with hereditary hemochromatosis. , 2010, Metabolism: clinical and experimental.

[51]  Qiang Yang,et al.  BOOST: A fast approach to detecting gene-gene interactions in genome-wide case-control studies , 2010, American journal of human genetics.

[52]  L. Hooper,et al.  The effects of oral iron supplementation on cognition in older children and adults: a systematic review and meta-analysis , 2010, Nutrition journal.

[53]  Toshiko Tanaka,et al.  A genome-wide association analysis of serum iron concentrations. , 2010, Blood.

[54]  P. Ponikowski,et al.  Ferric carboxymaltose in patients with heart failure and iron deficiency. , 2009, The New England journal of medicine.

[55]  T Wentzel-Larsen,et al.  The effect of blood donation frequency on iron status. , 2009, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[56]  V. Quesada,et al.  Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms. , 2009, Human molecular genetics.

[57]  Gloria Velasco,et al.  Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis , 2009, Haematologica.

[58]  H. Cordell.  Detecting gene–gene interactions that underlie human diseases , 2009, Nature Reviews Genetics.

[59]  L. Grummer-Strawn,et al.  Assessment of iron deficiency in US preschool children and nonpregnant females of childbearing age: National Health and Nutrition Examination Survey 2003-2006. , 2009, The American journal of clinical nutrition.

[60]  D. Bellissimo,et al.  Behavioral, biochemical, and genetic analysis of iron metabolism in high‐intensity blood donors , 2008, Transfusion.

[61]  L. de las Fuentes,et al.  Enhanced detection of genetic association of hypertensive heart disease by analysis of latent phenotypes , 2008, Genetic epidemiology.

[62]  D. Winge,et al.  Iron-Mediated Inhibition of Mitochondrial Manganese Uptake Mediates Mitochondrial Dysfunction in a Mouse Model of Hemochromatosis , 2008, Molecular medicine.

[63]  R. Cardigan.  Guide to the Preparation, Use and Quality Assurance of Blood Components (13th edn) , 2007 .

[64]  Rishard Salie,et al.  Effect of phlebotomy on hepcidin expression in hemojuvelin-mutant mice. , 2007, Blood cells, molecules & diseases.

[65]  N. Rooijen,et al.  Kupffer cells modulate iron homeostasis in mice via regulation of hepcidin expression , 2007, Journal of Molecular Medicine.

[66]  M. Sandhu,et al.  Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study , 2007, Diabetologia.

[67]  P. Lavori,et al.  Reduction of iron stores and cardiovascular outcomes in patients with peripheral arterial disease: a randomized controlled trial. , 2007, JAMA.

[68]  B. Newman,et al.  Iron depletion by whole‐blood donation harms menstruating females: The current whole‐blood‐collection paradigm needs to be changed , 2006, Transfusion.

[69]  D. McClain,et al.  Increased insulin secretory capacity but decreased insulin sensitivity after correction of iron overload by phlebotomy in hereditary haemochromatosis , 2006, Diabetologia.

[70]  B. Balkau,et al.  Ferritin and Transferrin Are Both Predictive of the Onset of Hyperglycemia in Men and Women Over 3 Years , 2006, Diabetes Care.

[71]  T. Ganz,et al.  Regulation of iron metabolism by hepcidin. , 2006, Annual review of nutrition.

[72]  Alan D. Lopez,et al.  Global burden of disease and risk factors , 2006 .

[73]  D. McClain,et al.  High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis , 2006, Diabetologia.

[74]  Patricio Yankilevich,et al.  Evaluating HapMap SNP data transferability in a large-scale genotyping project involving 175 cancer-associated genes , 2006, Human Genetics.

[75]  J. Fernández-Real,et al.  Iron stores, blood donation, and insulin sensitivity and secretion. , 2005, Clinical chemistry.

[76]  J. Seghatchian,et al.  Transferrin receptor in serum. A new tool in the diagnosis and prevention of iron deficiency in blood donors. , 2004, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[77]  P. Hinton,et al.  Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. , 2004, The American journal of clinical nutrition.

[78]  J. Manson,et al.  Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. , 2004, JAMA.

[79]  E. Opara.  Role of Oxidative Stress in the Etiology of Type 2 Diabetes and the Effect of Antioxidant Supplementation on Glycemic Control , 2004, Journal of Investigative Medicine.

[80]  L. Hulthén,et al.  High serum ferritin is not identical to high iron stores. , 2003, The American journal of clinical nutrition.

[81]  Christopher J. Earley,et al.  Restless legs syndrome , 2003, Current treatment options in neurology.

[82]  B. Burnand,et al.  Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial , 2003, BMJ : British Medical Journal.

[83]  Charles R Cantor,et al.  A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[84]  J. Fernández-Real,et al.  Blood letting in high-ferritin type 2 diabetes: effects on vascular reactivity. , 2002, Diabetes care.

[85]  E. Beutler,et al.  Seeking candidate mutations that affect iron homeostasis. , 2002, Blood cells, molecules & diseases.

[86]  Gaël Nicolas,et al.  The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. , 2002, The Journal of clinical investigation.

[87]  Joseph L Evans,et al.  Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. , 2002, Endocrine reviews.

[88]  N. Milman,et al.  Iron status in Danish women, 1984–1994: a cohort comparison of changes in iron stores and the prevalence of iron deficiency and iron overload , 2002, European journal of haematology.

[89]  N. Milman,et al.  Iron status in Danish men 1984–94: a cohort comparison of changes in iron stores and the prevalence of iron deficiency and iron overload , 2002, European journal of haematology.

[90]  J. Fernández-Real,et al.  Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. , 2002, Diabetes.

[91]  R. Stoohs,et al.  Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease. , 2002, Gastroenterology.

[92]  O Jolobe,et al.  Guidelines for the management of iron deficiency anaemia , 2001, Gut.

[93]  P. Bärtsch,et al.  Effects of iron repletion on blood volume and performance capacity in young athletes. , 2001, Medicine and science in sports and exercise.

[94]  P. Galan,et al.  Iron deficiency in Europe , 2001, Public Health Nutrition.

[95]  K. Rasmussen,et al.  Is There a Causal Relationship between Iron Deficiency or Iron-Deficiency Anemia and Weight at Birth, Length of Gestation and Perinatal Mortality? , 2001, The Journal of nutrition.

[96]  S. Gaztambide,et al.  Excess iron storage in patients with type 2 diabetes unrelated to primary hemochromatosis. , 2000, The New England journal of medicine.

[97]  E. Diamandis.  Elevated serum prostate-specific antigen levels in a woman with metastatic breast cancer. , 2000, The New England journal of medicine.

[98]  Kaaron Benson,et al.  Guide to the Preparation, Use and Quality Assurance of Blood Components , 1999 .

[99]  F. Facchini.  Effect of Phlebotomy on Plasma Glucose and Insulin Concentrations , 1998, Diabetes Care.

[100]  L. Ribas,et al.  Estudio SUVIMAX (Francia): el papel de los antioxidantes en la prevención del cáncer y la enfermedad cardiovascular , 1998 .

[101]  L. Hallberg,et al.  Iron absorption from the whole diet in men: how effective is the regulation of iron absorption? , 1997, The American journal of clinical nutrition.

[102]  L. Peltonen,et al.  How to tackle genetic loci predisposing to atherosclerosis? , 1997, Current opinion in lipidology.

[103]  C. Cantor,et al.  Matrix-assisted laser desorption/ionization mass spectrometry of immobilized duplex DNA probes. , 1995, Nucleic acids research.

[104]  P. Cutler.  Deferoxamine Therapy in High-Ferritin Diabetes , 1989, Diabetes.

[105]  E. Beutler,et al.  Iron therapy in chronically fatigued, nonanemic women: a double-blind study. , 1960, Annals of internal medicine.

[106]  C. Gassner,et al.  Matrix-assisted laser desorption/ionisation, time-of-flight mass spectrometry-based blood group genotyping--the alternative approach. , 2013, Transfusion medicine reviews.

[107]  J. Olynyk,et al.  Iron and hepatic carcinogenesis. , 2013, Critical reviews in oncogenesis.

[108]  R. Cancado,et al.  Blood donation, blood supply, iron deficiency and anemia - it is time to shift attention back to donor health , 2012, Revista brasileira de hematologia e hemoterapia.

[109]  G. A. Pereira,et al.  Etiology of anemia of blood donor candidates deferred by hematologic screening , 2012, Revista brasileira de hematologia e hemoterapia.

[110]  J. Krieger,et al.  Non-HFE hemochromatosis , 2012, Revista brasileira de hematologia e hemoterapia.

[111]  Klaus Meyer,et al.  Use of matrix-assisted laser desorption/ionization time-of-flight mass spectrometry for multiplex genotyping. , 2011, Advances in clinical chemistry.

[112]  Meredith P Millis,et al.  Medium-throughput SNP genotyping using mass spectrometry: multiplex SNP genotyping using the iPLEX® Gold assay. , 2011, Methods in molecular biology.

[113]  G. Marnellos,et al.  Qualitative and quantitative genotyping using single base primer extension coupled with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MassARRAY). , 2009, Methods in molecular biology.

[114]  Jerry Kaplan,et al.  Regulation of iron acquisition and storage: consequences for iron-linked disorders , 2008, Nature Reviews Molecular Cell Biology.

[115]  M. Fleming.  The regulation of hepcidin and its effects on systemic and cellular iron metabolism. , 2008, Hematology. American Society of Hematology. Education Program.

[116]  Dean T. Jamison,et al.  Measuring the Global Burden of Disease and Risk Factors, 1990–2001 , 2006 .

[117]  A. Rüfer,et al.  IRON BALANCE REMAINS STABLE IN LIFE-LONG BLOOD DONORS , 2005 .

[118]  L. Tilbrook.  Cross talk between iron metabolism and diabetes. , 2004, Annals of clinical biochemistry.

[119]  Alison M. Goate,et al.  The Candidate Gene Approach , 2000, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[120]  P. Galan,et al.  [The SUVIMAX (France) study: the role of antioxidants in the prevention of cancer and cardiovascular disorders]. , 1998, Revista espanola de salud publica.

[121]  T. Rouault,et al.  Hereditary hemochromatosis. , 1993, JAMA.

[122]  H. Gurling.  Application of molecular biology to mental illness. Analysis of genomic DNA and brain mRNA. , 1985, Psychiatric developments.